Company: MFAN
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001055160-25-000013
Chunk: 133

Company: MFA FINANCIAL, INC.
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 1
Chunk 133
---
 conditions of the award either in cash at the time dividends are paid by the Company or at the time of settlement of the RSU award, or for performance-based RSU awards, as a grant of stock at the time such awards are settled.  At June 30, 2025 and December 31, 2024, the Company had unrecognized compensation expense of $11.1 million and $6.3 million, respectively, related to RSUs.  The unrecognized compensation expense at June 30, 2025, is expected to be recognized over a weighted average period of 2.0 years.Restricted Stock The Company did not grant any shares of restricted common stock during the six months ended June 30, 2025 and 2024.  At June 30, 2025, the Company did not have any unvested shares of restricted common stock outstanding, and no restricted shares vested during the six months ended June 30, 2025 and 2024.Dividend Equivalents A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid typically in cash or other consideration at such times and in accordance with such rules as the Compensation Committee of the Board shall determine in its discretion.  Dividend equivalent payments are generally charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest. The Company made dividend equivalent payments associated with RSU awards of approximately $0.3 million and $0.6 million during the three and six months ended June 30, 2025, respectively, and approximately $0.3 million and $1.7 million during the three and six months ended June 30, 2024, respectively. In addition, no dividend equivalents rights awarded as separate instruments were granted during the six months ended June 30, 2025 and 2024.  

43  

Table of ContentsMFA FINANCIAL, INC.NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTSJUNE 30, 2025

 Expense Recognized for Equity-Based Compensation Instruments The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and six months ended